Autobio Diagnostics CO.,Ltd.
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Zhengzhou Antu Biotechnology Co., Ltd. was founded in 1998, focusing on the research and development, manufacturing, integration, and services of in vitro diagnostic reagents and instruments. Its products cover the fields of immunity, microbiology, biochemistry, molecular testing, and can provide comprehensive product solutions and overall services for medical laboratories. The company was listed on September 1, 2016 and is the first in vitro diagnostic production enterprise in China to be listed on the Shanghai main board. Antu Biotechnology has established a national recognized enterprise technology center, a national and local joint engineering laboratory for immune testing automation, and a Henan Provincial Immunodiagnostic Reagent Engineering Technology Research Center. It has undertaken multiple major national, provincial, and municipal scientific and technological projects, including two projects under the "863 Plan". Antu Biotechnology attaches great importance to product research and technological innovation, and always regards enhancing research and innovation capabilities as an important means to enhance the core competitiveness of the enterprise. The company attaches great importance to R&D investment, and in the past three years, R&D investment has exceeded 10% of operating revenue; Emphasize team building, with technical research and development personnel accounting for about one-third of the company's total workforce; Compared to international advanced technology, strict research and development process management; Focusing on the research and development of core raw materials, we have created a diagnostic antibody library targeting tens of thousands of antigen epitopes. The self-sufficiency rate of antigen and antibody in immune diagnostic reagent products is high, ensuring the stability and safety of supply. Antu Biotechnology is one of the enterprises with a large number of registered documents and a comprehensive product line in the industry. Antu Bio focuses on quality and pursues excellent manufacturing. In terms of reagent production, introduce automated production lines to improve product automation and flow operations, and enhance the level of refined management; In terms of instrument manufacturing, we will continue to increase our efforts in refined management and advocate for a craftsman spirit of pursuing excellence, excellence, and continuous optimization; In terms of quality management, we have passed certifications such as GMP, ISO9001, and ISO13485, strictly assessed quality management, and continuously promoted quality improvement. Antu Bio focuses on independent innovation and excellent manufacturing, while also emphasizing global resource integration. By integrating R&D innovation resources and even advanced products in the industry, we aim to provide medical laboratories with more diverse products. Antu Biotechnology adheres to the service philosophy of "user first, creating value", adheres to the customer-centered approach, continuously improves service standards and capabilities, and provides professional, timely, and thoughtful technical services to users across the country. While providing product technical services to users, we also provide quality control services and overall services for medical laboratories. Antu Biological's marketing network covers the whole country, and in terms of international marketing, the company's products have been sold to Europe, Asia, the Middle East, South America, Africa and other regions. The Antu Biological Extracorporeal Diagnosis Industrial Park under construction covers an area of over 250 acres and a construction area of over 500000 square meters. Upon full completion, it will become one of the largest in vitro diagnosis industrial bases in China. |
| Headquarter | Zhengzhou |
| Establish Date | 9/15/1999 |
| Listed Code | 603658.SH |
| Listed Date | 9/1/2016 |
| Chairman | Miao Yongjun. |
| CEO | Yang Zengli. |
| Website | www.autobio.com.cn |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
